cms glp 1 coverage The BALANCE Model: What CMS's GLP-1 Model Means for Eli Lilly and the Future of Obesity Treatment CMS GLP-1 Bridge Program |

This means that the modified substance is not only more durable but also remains effective at its job, which could lead to longer-lasting effects in the body

"Weight loss is already part of the recommendations for many patients with arthritis, but our study may indicate that medication such as Wegovy could have a dual effect -- both through weight loss and by increasing GLP-1 levels in the joints," Kragstrup said

The systematic review of various evidence and studies suggests that a higher dietary intake of B vitamins could lower the risk of advanced macular degeneration

Michel MS, Ptaschnyk T, Musial A et al: Objective and subjective changes in patients with Peyronie's disease after management with shockwave therapy

There is also an increased risk of diabetic retinopathy

Real-world evidence featured prominently at EHA 2026, with new studies presented across multiple haematological conditions, including PNH, ITP, HLH, myelofibrosis, haemophilia, von Willebrand disease, and other rare disorders